Hot Investor Mandate 2: VC Invests in Early Therapeutic Platforms and Revenue-Generating Medtech or Healthcare IT

3 Mar

A venture capital firm based in Massachusetts has two funds under management and is currently investing out of its second fund. The firm seeks to make equity investments into life science companies from early to late stages. The typical investment size ranges from $2 million to $4million. The firm plans to invest in 2-4 companies over the next 12 months and prefers to invest in companies based in US or Canada.

The firm is currently looking for new investment opportunities in life sciences. The firm is interested in therapeutic platform technologies from an early stage of development, and is also interested in healthcare IT, device and diagnostic companies that are generating at least $2 million in revenue. The firm is currently not interested in single asset therapeutics or pre-revenue diagnostics/medical devices.

The firm generally seeks to invest in private companies. The firm has no specific requirements for the company’s management team, and sometimes takes a board seat when investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: